Mark Cuban and Amazon Are Shaking Up Generic Drugs

February 6, 2023

(Wall Street Journal) – With the country’s largest insurers now owning those middlemen through a series of acquisitions, the way these pharmacy-benefit managers profit from the generic-drug supply chain has grown even more arcane. The lack of transparency is familiar to anyone who has filled a prescription at one pharmacy only to find out the price was much lower elsewhere.  (Read More)